Factors Associated with the Poor Coverage of Intermittent Preventive Treatment in Pregnant Women in the Pobè-Adja-Ouèrè-Kétou Health Zone in Benin
Tiendrebéogo, Justin
Factors Associated with the Poor Coverage of Intermittent Preventive Treatment in Pregnant Women in the Pobè-Adja-Ouèrè-Kétou Health Zone in Benin - 2015.
52
"World Health Organization estimates indicate 216 million malaria episodes in 2010, including 81% in the African region. One of the recommended means of prevention in pregnant women is intermittent preventive treatment, until 2012, two doses of sulfadoxine/pyrimethamine or three does for a woman living with HIV. In the Pobè-Adja-Ouèrè-Kétou health zone of Benin, coverage of intermittent preventive treatment remains low (49% against a forecast of 80%) several years after implementation of this strategy. We conducted a cross-sectional study in June and July 2012 to identify factors associated with low intermittent preventive treatment coverage in this area.A total of 339 women were interviewed and 48% of them received less than two doses of sulfadoxine pyrimethamine during their prenatal consultations. The variables associated with low intermittent preventive treatment coverage were low antenatal care coverage (p < ; 0.001) and a prenatal consultation in the private sector (p = 0.039). In the light of our results, actions must be taken by this health zone to encourage women to complete the four visits during pregnancy."
Factors Associated with the Poor Coverage of Intermittent Preventive Treatment in Pregnant Women in the Pobè-Adja-Ouèrè-Kétou Health Zone in Benin - 2015.
52
"World Health Organization estimates indicate 216 million malaria episodes in 2010, including 81% in the African region. One of the recommended means of prevention in pregnant women is intermittent preventive treatment, until 2012, two doses of sulfadoxine/pyrimethamine or three does for a woman living with HIV. In the Pobè-Adja-Ouèrè-Kétou health zone of Benin, coverage of intermittent preventive treatment remains low (49% against a forecast of 80%) several years after implementation of this strategy. We conducted a cross-sectional study in June and July 2012 to identify factors associated with low intermittent preventive treatment coverage in this area.A total of 339 women were interviewed and 48% of them received less than two doses of sulfadoxine pyrimethamine during their prenatal consultations. The variables associated with low intermittent preventive treatment coverage were low antenatal care coverage (p < ; 0.001) and a prenatal consultation in the private sector (p = 0.039). In the light of our results, actions must be taken by this health zone to encourage women to complete the four visits during pregnancy."
Réseaux sociaux